← SynDRA
Ckd-712
SynDRA canonical compound SYN2061593 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | IL6 | JAK2 | NFKB1 | STAT1 | TNF |
|---|
| Mechanism of action | NFkB pathway inhibitor |
|---|
Cross-references
Synonyms
- ckd712
- PW8215U0ZU
- RefChem:126650
- UNII-PW8215U0ZU
- orb1700847
- SCHEMBL5898906
- SCHEMBL29440266
- CDK-712
- AKOS040748147
- PD132865
- CS-0079925
- T27033
- SCHEMBL4249633
- JXFRKNGQHAAJKY-FERBBOLQSA-N
- S2KL1B0KXS
- UNII-S2KL1B0KXS
- (S)-YS-49HBrsalt
- GLXC-02078
- (S)-YS-49 HBrsalt
- CKD-712 hydrobromide
- SCHEMBL5898915
- MS-26370
- SCHEMBL5898981
- DA-45991
- SCHEMBL26186975
- orb1308928
- YS49 compound
- Ys-49?
- MFCD20926418
- RefChem:388482
- BRD-A26458246-004-02-1
- GLXC-04856
- AKOS030526408
- HY-15477
- BRD-A26458246-004-01-3
- 1-(1-Naphthylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol
- CHEBI:230394
- T13376
- DTXCID80388171
Look up Ckd-712 in the interactive SynDRA portal →